Literature DB >> 19293374

Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus.

Min Li1, Binh An Diep, Amer E Villaruz, Kevin R Braughton, Xiaofei Jiang, Frank R DeLeo, Henry F Chambers, Yuan Lu, Michael Otto.   

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has recently emerged worldwide. The United States, in particular, is experiencing a serious epidemic of CA-MRSA that is almost entirely caused by an extraordinarily infectious strain named USA300. However, the molecular determinants underlying the pathogenic success of CA-MRSA are mostly unknown. To gain insight into the evolution of the exceptional potential of USA300 to cause disease, we compared the phylogeny and virulence of USA300 with that of closely related MRSA clones. We discovered that the sublineage from which USA300 evolved is characterized by a phenotype of high virulence that is clearly distinct from other MRSA strains. Namely, USA300 and its progenitor, USA500, had high virulence in animal infection models and the capacity to evade innate host defense mechanisms. Furthermore, our results indicate that increased virulence in the USA300/USA500 sublineage is attributable to differential expression of core genome-encoded virulence determinants, such as phenol-soluble modulins and alpha-toxin. Notably, the fact that the virulence phenotype of USA300 was already established in its progenitor indicates that acquisition of mobile genetic elements has played a limited role in the evolution of USA300 virulence and points to a possibly different role of those elements. Thus, our results highlight the importance of differential gene expression in the evolution of USA300 virulence. This finding calls for a profound revision of our notion about CA-MRSA pathogenesis at the molecular level and has important implications for design of therapeutics directed against CA-MRSA.

Entities:  

Mesh:

Year:  2009        PMID: 19293374      PMCID: PMC2667066          DOI: 10.1073/pnas.0900743106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Staphylococcal pore-forming toxins.

Authors:  G Prévost; L Mourey; D A Colin; G Menestrina
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 2.  Pathogenicity and resistance islands of staphylococci.

Authors:  R P Novick; P Schlievert; A Ruzin
Journal:  Microbes Infect       Date:  2001-06       Impact factor: 2.700

3.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

4.  Antibodies to block Staph virulence.

Authors:  Michael Otto
Journal:  Chem Biol       Date:  2007-10

5.  Coexistence of Panton-Valentine leukocidin-positive and -negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region.

Authors:  Kunyan Zhang; Jo-Ann McClure; Sameer Elsayed; Jonathan Tan; John M Conly
Journal:  J Infect Dis       Date:  2008-01-15       Impact factor: 5.226

6.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

7.  A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection.

Authors:  Loren G Miller; Clifford Quan; Anthony Shay; Katayoun Mostafaie; Kiran Bharadwa; Nelly Tan; Kelli Matayoshi; Jason Cronin; Jennifer Tan; Grace Tagudar; Arnold S Bayer
Journal:  Clin Infect Dis       Date:  2007-01-12       Impact factor: 9.079

8.  Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA.

Authors:  Rong Wang; Kevin R Braughton; Dorothee Kretschmer; Thanh-Huy L Bach; Shu Y Queck; Min Li; Adam D Kennedy; David W Dorward; Seymour J Klebanoff; Andreas Peschel; Frank R DeLeo; Michael Otto
Journal:  Nat Med       Date:  2007-11-11       Impact factor: 53.440

9.  Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

Authors:  Binh An Diep; Henry F Chambers; Christopher J Graber; John D Szumowski; Loren G Miller; Linda L Han; Jason H Chen; Felice Lin; Jessica Lin; Tiffany HaiVan Phan; Heather A Carleton; Linda K McDougal; Fred C Tenover; Daniel E Cohen; Kenneth H Mayer; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Ann Intern Med       Date:  2008-01-30       Impact factor: 25.391

10.  Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification.

Authors:  Adam D Kennedy; Michael Otto; Kevin R Braughton; Adeline R Whitney; Liang Chen; Barun Mathema; Jose R Mediavilla; Kelly A Byrne; Larye D Parkins; Fred C Tenover; Barry N Kreiswirth; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

View more
  207 in total

1.  Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.

Authors:  Batu K Sharma-Kuinkel; Yuling Wu; David E Tabor; Hoyin Mok; Bret R Sellman; Amy Jenkins; Li Yu; Hasan S Jafri; Thomas H Rude; Felicia Ruffin; Wiley A Schell; Lawrence P Park; Qin Yan; Joshua T Thaden; Julia A Messina; Vance G Fowler; Mark T Esser
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

3.  Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives.

Authors:  Hwang-Soo Joo; Gordon Y C Cheung; Michael Otto
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

4.  Multidrug-resistant organisms, wounds and topical antimicrobial protection.

Authors:  Philip G Bowler; Sarah Welsby; Victoria Towers; Rebecca Booth; Andrea Hogarth; Victoria Rowlands; Alexis Joseph; Samantha A Jones
Journal:  Int Wound J       Date:  2012-05-29       Impact factor: 3.315

Review 5.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

Review 6.  Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Authors:  Lance R Thurlow; Gauri S Joshi; Anthony R Richardson
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-05

7.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 8.  Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments.

Authors:  Sana S Dastgheyb; Michael Otto
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

9.  Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Authors:  Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

10.  SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis.

Authors:  Tyler K Nygaard; Kyler B Pallister; Peter Ruzevich; Shannon Griffith; Cuong Vuong; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.